Maharashtra, India

Suprit Dilip Saoji

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Suprit Dilip Saoji in Pharmaceutical Sciences

Introduction

Suprit Dilip Saoji is an accomplished inventor based in Maharashtra, India, renowned for his significant contributions to pharmaceutical innovations. With a total of three patents to his name, he is at the forefront of developing formulations that improve the efficacy of existing medications.

Latest Patents

Suprit's latest patents focus on pharmaceutical compositions of cabozantinib. These inventive compositions consist of cabozantinib or its pharmaceutically acceptable salts, combined with at least one pharmaceutically acceptable excipient. Notably, these formulations demonstrate enhanced bioavailability when compared to currently marketed versions. His inventions also encompass the manufacturing processes for these compositions, as well as their applications in treating various disorders in human patients. The emphasis on improving the oral pharmaceutical compositions of cabozantinib underscores his dedication to advancing healthcare solutions.

Career Highlights

Currently, Suprit Dilip Saoji works at Slayback Pharma LLC, a company that is dedicated to the development of innovative pharmaceutical products. His work at this organization plays a crucial role in the advancement of therapeutic modalities that benefit patients in need.

Collaborations

Throughout his career, Suprit has collaborated with distinguished professionals in the field, including his coworkers Girish G Kore and Sushant Omprakash Dube. These collaborations not only enhance the innovative capacity of his projects but also reflect his commitment to teamwork in achieving pharmaceutical breakthroughs.

Conclusion

Suprit Dilip Saoji stands out as a visionary inventor whose patents pave the way for improved pharmaceutical formulations. By focusing on enhancing the bioavailability of important medications like cabozantinib, he contributes significantly to the field of medicine and the betterment of patient care. His continued work at Slayback Pharma LLC promises to bring forth further advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…